Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor

Bariatric surgeries, including vertical sleeve gastrectomy (VSG), resolve diabetes in 40–50% of patients. Studies examining the molecular mechanisms underlying this effect have centered on the role of the insulinotropic glucagon-like peptide 1 (GLP-1), in great part because of the ∼10-fold rise in i...

Descripción completa

Detalles Bibliográficos
Autores principales: Douros, Jonathan D., Lewis, Alfor G., Smith, Eric P., Niu, JingJing, Capozzi, Megan, Wittmann, April, Campbell, Jonathan, Tong, Jenny, Wagner, Constance, Mahbod, Parinaz, Seeley, Randy, D’Alessio, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054432/
https://www.ncbi.nlm.nih.gov/pubmed/29759973
http://dx.doi.org/10.2337/db18-0081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054432/
https://www.ncbi.nlm.nih.gov/pubmed/29759973
http://dx.doi.org/10.2337/db18-0081

Ejemplares similares